The review by researchers at Anglia Ruskin University in the UK looked at 30 published studies conducted in cell cultures and ...

AUVELITY is a first-in-class treatment, which targets the NMDA and sigma-1 receptors, approved for agitation associated with dementia due to ...

Alzheimer’s disease may begin its biological progression far earlier than symptoms suggest, with subtle shifts in brain and blood markers emerging decades in advance.

Researchers at the Indiana University School of Medicine have developed a new way to read the brain's "energy network ...

Subtle biological changes linked to Alzheimer's disease may begin as early as the late 50s—decades before memory loss or ...

A newly identified trigger of brain inflammation could offer a fresh target for slowing Alzheimer’s progression.

Researchers have identified a new potential weapon against Alzheimer’s: blocking a protein called PTP1B. In mice, this approach boosted memory and helped brain immune cells clear harmful plaque ...

According to the survey released this month, 9 in 10 adults aged 40 and older said brain health is a top priority, on par ...

STING" molecular switch drives Alzheimer's brain inflammation. Blocking this switch protects synapses in new study.

Rumors about tech billionaire Bill Gates' supposed involvement in remedies for Alzheimer's disease or dementia circulated for ...

The Alzheimer's Association brought "Help & Hope" to the Card Community Center, an event focused on brain health awareness ...

Gates is a supporter of Alzheimer’s research, but scammers are using his name and likeness to promote fraudulent “cures” for the disease.